Senior R&D exec Sue Dillon jumps ship at J&J, launches mystery biotech startup Aro with Centyrins tech - Endpoints News

Endpoints News
Senior R&D exec Sue Dillon jumps ship at J&J, launches mystery biotech startup Aro with Centyrins tech
Endpoints News
Two former executive heavyweights at Johnson & Johnson have left the pharma giant to launch a rather stealthy startup called Aro Biotherapeutics – and they are starting out with some drug tech they're already closely familiar with. Karyn O'Neil. The ...